Insider Shareholders with Direct Ownership of Genprex, Inc. (GNPX)
This section provides a comprehensive overview of the insiders with direct ownership of Genprex, Inc. (GNPX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Genprex, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Catherine M Vaczy
EVP GC Chief Strategy Officer |
265,000 | 0 | 265,000 $424,000 | 2 |
Apr 21, 2023
Added 7.02%
|
|
Hermant Kumar
Chief Mfgr & Tech Officer |
200,000 | 0 | 200,000 $320,000 | 1 |
Feb 18, 2023
Added 50.0%
|
|
Brent M Longnecker
Director |
138,795 | 0 | 138,795 $222,072 | 2 |
Jun 27, 2023
Added 47.14%
|
|
William R Wilson Jr.
Director |
123,795 | 0 | 123,795 $198,072 | 1 |
Jun 27, 2023
Added 50.0%
|
|
Toscano Jose Antonio Moreno
Director |
123,795 | 0 | 123,795 $198,072 | 1 |
Jun 27, 2023
Added 50.0%
|
|
John Rodney Varner
Chairman, President and CEO |
625,000 | 2,642 | 26,352 $42,163 | 2 |
Feb 18, 2024
Reduced 9.11%
|
|
Ryan M. Confer
Chief Financial Officer |
361,973 | 1,126 | 9,763 $15,620 | 3 |
Feb 18, 2024
Reduced 10.34%
|
|
Mark Stanley Berger
Chief Medical Officer |
245,000 | 1,319 | 4,806 $7,689 | 2 |
Feb 18, 2024
Reduced 21.53%
|